B
Bull
Bull · 25%BGM
$14.82
Scenario price
$0.273
+0.001 (+0.37%)At close
Loading chart…
- High
- 0.280
- Open
- 0.280
- VWAP
- 0.28
- Vol
- 31.99K
- Mkt Cap
- —
- Low
- 0.278
- Amount
- 8.86K
- EV/EBITDA, TTM
- 0.00
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
AI analysis of BGM Group Ltd (BGM)
buyBGM Group Ltd appears to be a good buy right now due to its recent price action and technical indicators. The current price is $0.33, and it has experienced a significant 5-day change of +24.86%, indicating strong momentum. Additionally, the RSI is at 77.156, suggesting that the stock is in a strong bullish trend. However, investors should be cautious as the stock has a high forward P/E of 0, indicating uncertainty about future earnings. The main risk is its year-to-date change of -90.85%, reflecting past volatility and potential challenges ahead.
Valuation Metrics
The current forward P/E ratio for BGM Group Ltd (BGM) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for BGM
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
2.012-17BenzingaToro, DBV Technologies, Udemy, ABM Industries, and Other Major Stocks Rising on Wednesday
2.009-24BenzingaMajor Stocks Including Freeport-McMoRan, Harmony Biosciences, and Cohu Decline on Wednesday
2.009-17BenzingaMajor Stocks Including Lyft, Oruka Therapeutics, Roivant Sciences, and Workday Rise on Wednesday
9.507-23PRnewswireBGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025
8.505-28NewsfilterFrom Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts
BGM FAQ — answered by Alphio AI
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market. It operates in the Healthcare sector.
BGM Group Ltd appears to be a good buy right now due to its recent price action and technical indicators. The current price is $0.33, and it has experienced a significant 5-day change of +24.86%, indicating strong momentum. Additionally, the RSI is at 77.156, suggesting that the stock is in a strong bullish trend. However, investors should be cautious as the stock has a high forward P/E of 0, indicating uncertainty about future earnings. The main risk is its year-to-date change of -90.85%, reflecting past volatility and potential challenges ahead.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.